We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products: More products

Download Mobile App




Molecular Assays Developed to Differentiate Bordetella Species

By LabMedica International staff writers
Posted on 12 Feb 2014
Bordetella parapertussis is a causative agent of whooping cough or pertussis in humans and B. More...
bronchiseptica causes a wide variety of respiratory infections in mammals including humans, and a specific diagnostic assay would be useful for routine use or for use in reference laboratories.

The presence of B. bronchiseptica can confound current molecular B. pertussis or B. parapertussis diagnostic test results and although B. bronchiseptica may be rare, its prevalence is not known with any certainty, and it may cause erroneous diagnosis, in particular in adolescents and adults.

Scientists at the Institute of Chemical Technology (Prague, Czech Republic) with colleagues in France collected reference strains of B. bronchiseptica, B. parapertussis, B. pertussis, and B. petrii, B. holmesii, and clinical isolates of these species and sputum samples collected from patients with confirmed B. bronchiseptica infection by culture.

Clinical isolates and reference strains were cultivated at 36 °C for 48 hours (B. bronchiseptica, B. parapertussis, and B. petrii) to 72 hours (B. pertussis and B. holmesii) on Bordet Gengou agar containing 15% defibrinated sheep blood. Bacterial DNA was isolated with DNeasy blood and tissue kits (Qiagen GmbH; Hilden, Germany). Multilocus sequence typing (MLST) was also performed. A real-time polymerase chain reaction (PCR) assay was carried out and analyzed on the LightCycler 480 (Roche Applied Science; Penzberg, Germany).

Analysis of the sequences revealed a region that is highly conserved in the genomes of all clinical isolates of B. bronchiseptica and B. parapertussis. This region contains regulatory sites, including a ribosome-binding site and polymerase-binding site. The targeted region of several clinical isolates of both species was sequenced and alignment of the sequences allowed the development of a two-step real-time PCR assay. The sensitivity of this real-time PCR assay for detection of B. bronchiseptica/B. parapertussis and B. parapertussis was 24 and 22 colony forming units (CFU) per reaction, respectively.

The authors concluded that the first PCR assay detected the DNA of all clinical isolates of both B. bronchiseptica and B. parapertussis tested. The second PCR assay detected only the DNA of B. parapertussis clinical isolates, thereby allowing discrimination between B. parapertussis and B. bronchiseptica. The study was published on January 14, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Institute of Chemical Technology
Qiagen GmbH
Roche Applied Science 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Manual Pipetting Aid
Pipette Controllers macro
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.